Role of Interleukin(IL)-6 in NK Activity to Hypoxic-Induced Highly Invasive Hepatocellular Carcinoma(HCC) Cells
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Natural killer (NK) cell dysfunctions against hepatocellular carcinoma (HCC) in a hypoxic environment. Many solid tumors are present in a hypoxic condition, which changes the effector function of various immune cells. The transcription of hypoxic-inducible factors (HIFs) in cancer cells make it possible to adapt to their hypoxic environment and to escape the immune surveillance of NK cells. Recently, the correlation between the transcription of HIF-1α and pro-inflammatory cytokines has been reported. Interleukin (IL)-6 is higher in cancers with a highly invasive ability, and is closely related to the metastasis of cancers. This study showed that the expression of HIF-1α in HCC cells was associated with the presence of IL-6 in the environment of HCC-NK cells. Blocking of IL-6 by antibody in the HCCNK interaction changed the production of several cytokines including TGF-β, IL-1, IL-18 and IL-21. Interestingly, in a co-culture of HIF-1α-expressed HCC cells and NK cells, blocking of IL-6 increased the production of IL-21 in their supernatants. In addition, the absence of IL-6 significantly enhanced the cytotoxic ability and the expression of the activating receptors (NKG2D, NKp44, and NKG2C) in NK cells to HIF-1α-expressed HCC cells. These effects might be made by the decreased expression of HIF-1α in HCC cells through the inhibited phosphorylation of STAT3. In conclusion, the absence of IL6 in the interaction of HIF-1α-expressed HCC cells and NK cells could enhance the antitumor activity of NK cells to HCC cells.
Abstract
Natural killer (NK) cell dysfunctions against hepatocellular carcinoma (HCC) in a hypoxic environment. Many solid tumors are present in a hypoxic condition, which changes the effector function of various immune cells. The transcription of hypoxic-inducible factors (HIFs) in cancer cells make it possible to adapt to their hypoxic environment and to escape the immune surveillance of NK cells. Recently, the correlation between the transcription of HIF-1α and pro-inflammatory cytokines has been reported. Interleukin (IL)-6 is higher in cancers with a highly invasive ability, and is closely related to the metastasis of cancers. This study showed that the expression of HIF-1α in HCC cells was associated with the presence of IL-6 in the environment of HCC-NK cells. Blocking of IL-6 by antibody in the HCCNK interaction changed the production of several cytokines including TGF-β, IL-1, IL-18 and IL-21. Interestingly, in a co-culture of HIF-1α-expressed HCC cells and NK cells, blocking of IL-6 increased the production of IL-21 in their supernatants. In addition, the absence of IL-6 significantly enhanced the cytotoxic ability and the expression of the activating receptors (NKG2D, NKp44, and NKG2C) in NK cells to HIF-1α-expressed HCC cells. These effects might be made by the decreased expression of HIF-1α in HCC cells through the inhibited phosphorylation of STAT3. In conclusion, the absence of IL6 in the interaction of HIF-1α-expressed HCC cells and NK cells could enhance the antitumor activity of NK cells to HCC cells.
참고문헌 (58)
- Yuan Y, "Role of the tumor microenvironment in tumor progression and the clinical applications (Review)", Oncol. Rep, 35, pp.2499~2515 (2016)
- Zhang W, "IL-1 Signaling in tumor microenvironment", Adv. Exp. Med. Biol, 1240, pp.1~23 (2020)
- Balkwill FR, "Human tumor xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferons", Cancer Res, 46, pp.3990~3993 (1986)
- Magidey-Klein K, "IL-6 contributes to metastatic switch via the differentiation of monocytic-dendritic progenitors into prometastatic immune cells", J. ImmunoTher. Cancer, 9, pp.e002856~ (2021)
- Shacter E, "Elevation of interleukin-6 in response to a chronic inflammatory stimulus in mice:inhibition by indomethacin", Blood, 80, pp.194~202 (1992)
- Lee HH, "Antitumor and anti-invasive effect of apigenin on human breast carcinoma through suppression of IL-6 expression", Int. J. Mol. Sci, 20, pp.3143~ (2019)
- Shakiba E, "Evaluation of serum interleukin-6 levels in hepatocellular carcinoma patients: a systematic review and meta-analysis", Clin. Exp. Hepatol, 4, pp.182~190 (2018)
- Soresi M, "Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma", World J. Gastroenterol, 12, pp.2563~2568 (2006)
- Doherty DG, "Innate and adaptive lymphoid cells in the human liver", Immunol. Rev, 174, pp.5~20 (2000)
- Malmberg KJ, "Natural killer cell-mediated immunosurveillance of human cancer", Semin. Immunol, 31, pp.20~29 (2017)
- Mikulak J, "Hepatic natural killer cells: organ-specific sentinels of liver immune homeostasis and physiopathology", Front. Immunol, 10, pp.946~ (2019)
- 이환희, "Natural killer cells and tumor metastasis", Archives of Pharmacal Research, 40(9), pp.1037~1049 (2017), 대한약학회
- Crane CA, "TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients", Neuro. Oncol, 12, pp.7~13 (2010)
- Wong JL, "IL-18-primed helper NK cells collaborate with dendritic cells to promote recruitment of effector CD8+ T cells to the tumor microenvironment", Cancer Res, 73, pp.4653~4662 (2013)
- Erler JT, "Hypoxia-mediated down-regulation of Bid and Bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance", Mol. Cell. Biol, 24, pp.2875~2889 (2004)
- Peng XH, "Cross-talk between epidermal growth factor receptor and hypoxiainducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression", J. Biol. Chem, 281, pp.25903~25914 (2006)
- Van Meir E, "Hypoxia-mediated selection of cells with diminished apoptotic potential to solid tumours", Neurosurgery, 39, pp.878~879 (1996)
- Kondo A, "Hypoxia-induced enrichment and mutagenesis of cells that have lost DNA mismatch repair", Cancer Res, 61, pp.7603~7607 (2001)
- Dai X, "Association of PD-L1 and HIF-1α coexpression with poor prognosis in Hepatocellular Carcinoma", Transl. Oncol, 11, pp.559~566 (2018)
- Lu Y, "Hypoxia-mediated immune evasion of pancreatic carcinoma cells", Mol. Med. Rep, 11, pp.3666~3672 (2015)
- Bettelli E, "Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells", Nature, 441, pp.235~238 (2006)
- Dang Eric V, "Control of TH17", Treg balance by hypoxia-inducible factor 1, 2011, pp.146, 772~784
- Wang L, "IL-17 enhances tumor development in carcinogen-induced skin cancer", Cancer Res, 70, pp.10112~10120 (2010)
- Chang SH, "T helper 17 cells play a critical pathogenic role in lung cancer", Proc. Natl. Acad. Sci. USA, 111, pp.5664~5669 (2014)
- Tobin AJ, "Lipoprotein lipase hydrolysis products induce pro-inflammatory cytokine expression in triple-negative breast cancer cells", BMC Res. Notes, 14, pp.315~ (2021)
- Pegram HJ, "Activating and inhibitory receptors of natural killer cells", Immunol. Cell Biol, 89, pp.216~224 (2011)
- Singh V, "Apoptosis and pharmacological therapies for targeting thereof for cancer therapeutics", Sci, 4, pp.15~ (2022)
- Xu S, "IL-6 promotes nuclear translocation of HIF-1α to aggravate chemoresistance of ovarian cancer cells", Eur. J. Pharmacol, 894, pp.173817~ (2021)
- Croce M, "IL-21: a pleiotropic cytokine with potential applications in oncology", J. Immunol. Res, 2015, pp.696578~ (2015)
- Skak K, "Interleukin-21 activates human natural killer cells and modulates their surface receptor expression", Immunology, 123, pp.575~583 (2008)
- Gotthardt D, "STATs in NK-cells: the good, the bad, and the ugly", Front. Immunol, 7, pp.694~ (2016)
- Hwan Hee Lee, "Attenuated anti‑tumor activity of NK‑92 cells by invasive human breast carcinoma MDA‑MB‑231 cells", Molecular & Cellular Toxicology, 16(2), pp.139~147 (2020), 대한독성 유전단백체 학회
- Li R, "Pro-inflammatory cytokines in the formation of the pre-metastatic niche", Cancers, 12, pp.3752~ (2020)
- Heichler C, "STAT3 activation through IL-6", IL-11 in cancerassociated fibroblasts promotes colorectal tumour development and correlates with poor prognosis, 2020, pp.69, 1269~1282
- Silva EM, "High systemic IL-6 is associated with worse prognosis in patients with non-small cell lung cancer", PLoS One, 12, pp.e0181125~ (2017)
- Zhao H, "Inflammation and tumor progression: signaling pathways and targeted intervention", Signal Transduct. Target. Ther, 6, pp.263~ (2021)
- Xu J, "IL-6", STAT3 Is a promising therapeutic target for hepatocellular carcinoma, 2021, pp.11, 760971~
- Cifaldi L, "Inhibition of natural killer cell cytotoxicity by interleukin-6: Implications for the pathogenesis of macrophage activation syndrome", Arthritis Rheumatol, 67, pp.3037~3046 (2015)
- Gao Y, "Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells", Nat. Immunol, 18, pp.1004~1015 (2017)
- Palomares O, "Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-β", Genes Immun, 15, pp.511~520 (2014)
- Jelicic K, "The HIV-1 envelope protein gp120 impairs B cell proliferation by inducing TGF-β1 production and FcRL4 expression", Nat. Immunol, 14, pp.1256~1265 (2013)
- Terme M, "IL-18 induces PD-1–dependent immunosuppression in cancer", Cancer Res, 71, pp.5393~5399 (2011)
- Li Y, "IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response", J. Immunol, 175, pp.2261~2269 (2005)
- Wu J, "IL-6 and IL-8 secreted by tumour cells impair the function of NK cells via the STAT3 pathway in oesophageal squamous cell carcinoma", J. Exper. Clin. Cancer Res, 38, pp.321~ (2019)
- Qiu JG, "Apigenin inhibits IL-6 transcription and suppresses esophageal carcinogenesis", Front. Pharmacol, 10, pp.1002~ (2019)
- 이환희, "Apigenin Increases Natural Killer Cytotoxicity to Human Hepatocellular Carcinoma Expressing HIF-1α through High Interaction of CD95", CD95L, 2022, pp.32(4), 397~404[DOI]
- Chouaib S, "Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer", Oncogene, 36, pp.439~445 (2017)
- Noman MZ, "Hypoxia: a key player in antitumor immune response. A review in the theme: cellular responses to hypoxia", Am. J. Physiol. Cell Physiol, 309, pp.C569~C579 (2015)
- Noman MZ, "PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation", J. Exper. Med, 211, pp.781~790 (2014)
- Mancino A, "Divergent effects of hypoxia on dendritic cell functions", Blood, 112, pp.3723~3734 (2008)
- Laderoute KR, "The response of c-jun", AP-1 to chronic hypoxia is hypoxia-inducible factor 1 alpha dependent, 2002, pp.22, 2515~2523
- Conway EM, "Molecular mechanisms of blood vessel growth", Cardiovasc. Res, 49, pp.507~521 (2001)
- Balsamo M, "Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC", Eur. J. Immunol, 43, pp.2756~2764 (2013)
- Sarkar S, "Hypoxia induced impairment of NK cell cytotoxicity against multiple myeloma can be overcome by IL-2 activation of the NK cells", PLoS One, 8, pp.e64835~ (2013)
- Brady J, "IL-21 induces the functional maturation of murine NK cells", J. Immunol, 172, pp.2048~2058 (2004)
- de Rham C, "The proinflammatory cytokines IL-2, IL-15 and IL-21modulate the repertoire of mature human natural killer cell receptors", Arthritis Res. Ther, 9, pp.R125~ (2007)
- Wendt K, "Interleukin-21 differentially affects human natural killer cell subsets", Immunology, 122, pp.486~495 (2007)
- Gotthardt D, "Loss of STAT3 in murine NK cells enhances NK celldependent tumor surveillance", Blood, 124, pp.2370~2379 (2014)